Texas Is All-in on AI Data Centers. Guess Who Benefits...

The state of Texas recently made a critical change to its laws... In a quest to become the AI data center capital of the world. Now, these giant buildings are popping up everywhere in Texas...

Charles River Laboratories International Inc
NYSE:CRL
$170.88

Financials

Curr Year EPS Estimate10.19
Next Quarter EPS Estimate2.38
Profit Margin-2.07%
Operating Margin11.94
Return on Assets0.04
Return on Equity-0.02
Revenue4B
Earnings Per Share-1.31
Revenue Per Share79.63
Gross Profit1,411,084,032
Quarterly Revenue Growth0.01

General

NameCharles River Laboratories International Inc
TickerCRL
ExchangeNYSE
SectorHealthcare
IndustryDiagnostics & Research
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees18,700

About Charles River Laboratories International Inc

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies. It utilizes Logica, a platform offering from Valo Health, to identify advanceable small molecule leads. It provides contract vivarium operation services to biopharmaceutical clients. The company has strategic collaborations with Parker Institute for Cancer Immunotherapy and Children's Hospital Los Angeles across its contract development and manufacturing organization. In additionally, It has a strategic alliance with Francis Crick Institute (Crick), Inc. for the development of Antibody-Drug Conjugate (ADC) drug discovery and development. The company was founded in 1947 and is headquartered in Wilmington

Earnings

Popular

Wall Street Enters Its Strongest Month: These 7 Stocks Often Crush It

November is historically Wall Street's strongest month. These 7 stocks often delivered standout gains in recent decades.

The $43B Big Pharma Story is Starting Over-With a New Player - Ad

Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.

Warren Buffett Opens Up About The Biggest Investing Blunders Of His Career — Here They Are

Over the decades, the "Oracle of Omaha" has shared candid reflections on his biggest blunders, from emotional decisions to missed opportunities, all of which provide timeless investing insights.

On November 18, a powerful new law signed by President Trump will trigger a radical shift in America's money system... - Ad

When a small group of private companies - not the Fed - will perform a major mint of a new kind of money. And those who act before this new system fully kicks in could see gains as high as 40X by 2032. But those who fail to prepare will be blindsided by this sea change to the U.S. dollar.

Donald Trump Jr.-Linked Drone Maker Unusual Machines Wins Major Pentagon Deal

Unusual Machines secures its largest Pentagon drone contract to date, with Trump Jr. serving as an adviser but not involved in the deal.

A Tiny Biotech Just Posted 10× Stronger Cancer Results - Ad

Early studies show this breakthrough delivery platform would make cancer treatments safer and more powerful. Now, with Big Pharma watching closely, investors are starting to take notice of what could be the next major biotech story.

Move Over, Musk—The World's Richest Woman Joined the $100B Club

Alice Walton, daughter of Walmart founder Sam Walton, is the richest woman in the world worth more than $100 billion.

Anthony Scaramucci Calls Zohran Mamdani's Win An 'Anger-Based Reaction' To Boomer Policies, Says New NYC Mayor Could Become 'Popular' If...

Anthony Scaramucci, the founder of SkyBridge Capital, described Zohran Mamdani’s victory in New York City's mayoral race as an “anger-based reaction” by the young people against the policies of the boomer generation's political elites.

Is Big Pharma's Next Target Already in Play? - Ad

A small biotech may have cracked one of medicine's biggest problems-how to deliver cancer drugs safely and effectively. With patented technology and promising early data, it's already catching the attention of Big Pharma.

Nation's largest fleet of police Cybertrucks to patrol Las Vegas

LAS VEGAS (AP) — The nation's largest police fleet of Tesla Cybertrucks is set to begin patrolling the streets of Las Vegas in November thanks to a donation from a U.S. tech billionaire, raising concerns about the blurring of lines between public and private interests.

San Francisco mayor proposes denser housing to tackle affordability crisis

SAN FRANCISCO (AP) — San Francisco Mayor Daniel Lurie is trying to get more homes built for people like Liam Murphy: a fifth-generation city kid who found himself repeatedly outbid for tiny two-bedroom houses that wound up selling for $1.6 million.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as January 29.

"Tech Prophet" Who Predicted the iPhone Now Predicts... - Ad

George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit before November 18's bombshell.

Amazon Strikes $38B OpenAI Deal, Wedbush Hikes Target To Street-High

Wedbush analysts Dan Ives and Scott Devitt raise the price target on Amazon stock from $330 to a Street high of $340

Pete Hegseth Says War Department Preparing For 'Action' In Nigeria

U.S. Defense Secretary Hegseth agrees with Trump's order to prepare for action in Nigeria to stop the killing of Christians by Islamist militants.

Central Banks Are Buying More Gold Than Ever-And This U.S. Miner Is Ready to Oblige - Ad

Central banks are rapidly increasing their gold reserves-now nearly 20% of global assets. With rising demand and geopolitical pressure, U.S. gold supply is becoming more strategic than ever.

Nvidia, TSMC Unveil The First US-Made Blackwell Wafer, But Analyst Ming-Chi Kuo Flags This Overlooked Detail

Nvidia Corp (NASDAQ: NVDA) has introduced the first U.S.-made Blackwell wafer, a crucial component for AI chips, at Taiwan Semiconductor Manufacturing Co's (NYSE: TSM) facility in Phoenix.

How To Earn $500 A Month From UnitedHealth Group Stock Ahead Of Q3 Earnings

UNH to release Q3 earnings before opening bell on Tuesday. Analysts predict $2.81/share, down from $7.15/share in 2019. Dividend yield at 2.44%.

Gold Bars Are Pouring, but This Miner is Still Priced Like a Startup - Ad

You'd expect a gold miner with production, a full refinery, and big-name investors to be trading at a premium. But this one? It's still under $1

XRP Down 4%: Why $2.30 Is The Last Defense Before A Flush To $1.60

XRP (CRYPTO: XRP) is down 4% to $2.39 on Wednesday as traders brace for a potential breakdown below $2.30 — the final support before a deeper retracement that could erase months of gains.

What's Going On With Archer-Daniels-Midland Today?

ADM edges higher after a Q3 EPS beat, revenue miss, mixed segment results, and a lowered 2025 profit outlook.

From Ore to Gold Bars-This Nevada Mine Is Already Producing - Ad

Most juniors explore...Few actually produce. This one's already pouring gold thanks to infrastructure that would cost tens of millions to build today. With major land holdings and room to scale, it's one to watch.

China and ASEAN sign expanded free trade pact

KUALA LUMPUR, Malaysia (AP) — China signed an expanded version of a free trade agreement with the as both face increased protectionism from the United States, and Chinese Premier Li Qiang emphasized his country's close ties with the region.

Consumer Tech News (Oct 27-31): Nvidia Surpasses $5T Market Cap, Trump-Xi Meeting Concludes, Big Tech Report Earnings & More

Apple, Amazon, Microsoft, and Alphabet beat Q3 estimates with revenue and earnings growth. Trump and Xi conclude high-stakes meeting with trade, soybean, and resource agreements, potentially impacting U.S.-China economic relations and global markets.

Texas Is All-in on AI Data Centers. Guess Who Benefits... - Ad

The state of Texas recently made a critical change to its laws... In a quest to become the AI data center capital of the world. Now, these giant buildings are popping up everywhere in Texas...

Trump Commutes Former Rep. George Santos' Seven-Year Prison Term: '... Has Been Horribly Mistreated'

President Donald Trump announced on Friday that he commuted the prison sentence of former congressman George Santos (R-N.Y.), ordering his immediate release.

The $43B Big Pharma Story is Starting Over-With a New Player - Ad

Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.

Court Blocks Trump's SNAP Reductions, But Stricter Eligibility Rules Begin

New work requirements for SNAP begin Saturday, but benefits may not be issued through November due to the government shutdown.

On November 18, a powerful new law signed by President Trump will trigger a radical shift in America's money system... - Ad

When a small group of private companies - not the Fed - will perform a major mint of a new kind of money. And those who act before this new system fully kicks in could see gains as high as 40X by 2032. But those who fail to prepare will be blindsided by this sea change to the U.S. dollar.

How the NFL is aiming to broaden its appeal to women

At this year’s NFL draft, some of the league’s top prospects were asked a few questions they weren’t used to.

A Tiny Biotech Just Posted 10× Stronger Cancer Results - Ad

Early studies show this breakthrough delivery platform would make cancer treatments safer and more powerful. Now, with Big Pharma watching closely, investors are starting to take notice of what could be the next major biotech story.

Microsoft's quarterly sales and profit surge, beating Wall Street expectations

REDMOND, Wash. (AP) — Microsoft on Wednesday reported its quarterly sales grew 18% to $77.7 billion.

Recommended

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright finstrategist.com
Privacy Policy | Terms of Service